Blood Test for Early Diagnosis of Alzheimer’s Disease
Summary and conclusions
SBU Alert Report No. 2012-01
Swedish Council on Health Technology Assessment
December 12, 2012
Currently, no biomarkers in blood can be used to diagnose Alzheimer’s disease.
Of the four biomarkers studied, only platelet APP has shown differences between sick and healthy individuals. For the other biomarkers, the difference between sick and healthy people is insignificant.
Large, independent studies are needed to determine whether platelet APP in blood tests could serve as a diagnostic tool.
Studies using refined, highly sensitive measurement methods are needed to identify more biomarkers that could serve as diagnostic tools.
Preliminary version: HTML in process
Copyright © 2012 by the Swedish Council on Health Technology Assessment. All content unless otherwise noted is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Bookshelf ID: NBK285444, PMID: 26153602
